anti-PDGFR alpha monoclonal antibody MEDI-575
Term · Oncology and biomedicine · MLC-T-ONC-010996
A humanized monoclonal antibody directed against the platelet-derived growth factor receptor (PDGFR) alpha with potential antineoplastic activity. Anti-PDGFR alpha monoclonal antibody MEDI-575 inhibits activation of the cell-surface tyrosine kinase PDGFR alpha subunit and subsequent triggering of mitogenic signaling pathways, including the JAK/STAT, PI3K/Akt, and MAP kinase pathways. PDGFR alpha acts as a mitogenic signaling receptor for cells of mesenchymal origin and inhibition of receptor activity may inhibit tumor cell proliferation.
| Identifier | MLC-T-ONC-010996 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | anti-platelet-derived growth factor receptor alpha monoclonal antibody MEDI-575 |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-010996",
"term": "anti-PDGFR alpha monoclonal antibody MEDI-575",
"field": "Oncology and biomedicine",
"definition": "A humanized monoclonal antibody directed against the platelet-derived growth factor receptor (PDGFR) alpha with potential antineoplastic activity. Anti-PDGFR alpha monoclonal antibody MEDI-575 inhibits activation of the cell-surface tyrosine kinase PDGFR alpha subunit and subsequent triggering of mitogenic signaling pathways, including the JAK/STAT, PI3K/Akt, and MAP kinase pathways. PDGFR alpha acts as a mitogenic signaling receptor for cells of mesenchymal origin and inhibition of receptor activity may inhibit tumor cell proliferation.",
"synonyms": [
"anti-platelet-derived growth factor receptor alpha monoclonal antibody MEDI-575"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/anti-pdgfr-alpha-monoclonal-antibody-medi-575/"
}
Record 2,126 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.